1. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015) Authors: Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015) Authors: Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Benefit‐Risk Assessment of Nivolumab 240 mg Every 2 Weeks in Chinese Patients With Advanced and Metastatic Solid Tumors. (14th February 2021) Authors: Sheng, Jennifer; Zhang, Jason; Baudelet, Christine; Roy, Amit Journal: Journal of clinical pharmacology Issue: Volume 61:Number 8(2021) Page Start: 1045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Issue 10272 (30th January 2021) Authors: Baas, Paul; Scherpereel, Arnaud; Nowak, Anna K; Fujimoto, Nobukazu; Peters, Solange; Tsao, Anne S; Mansfield, Aaron S; Popat, Sanjay; Jahan, Thierry; Antonia, Scott; Oulkhouir, Youssef; Bautista, Yolanda; Cornelissen, Robin; Greillier, Laurent; Grossi, Francesco; Kowalski, Dariusz; Rodríguez-Cid,... Journal: Lancet Issue: Volume 397:Issue 10272(2021) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451. Issue 12 (20th April 2021) Authors: Owonikoko, Taofeek K.; Park, Keunchil; Govindan, Ramaswamy; Ready, Neal; Reck, Martin; Peters, Solange; Dakhil, Shaker R.; Navarro, Alejandro; Rodríguez-Cid, Jerónimo; Schenker, Michael; Lee, Jong-Seok; Gutierrez, Vanesa; Percent, Ivor; Morgensztern, Daniel; Barrios, Carlos H.; Greillier, Laurent... Journal: Journal of clinical oncology Issue: Volume 39:Issue 12(2021) Page Start: 1349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗